Annual EBIT
-$134.76 M
-$65.12 M-93.51%
December 31, 2024
Summary
- As of March 10, 2025, LAB annual earnings before interest & taxes is -$134.76 million, with the most recent change of -$65.12 million (-93.51%) on December 31, 2024.
- During the last 3 years, LAB annual EBIT has fallen by -$74.92 million (-125.21%).
- LAB annual EBIT is now -819.15% below its all-time high of -$14.66 million, reached on December 1, 2010.
Performance
LAB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$29.74 M
-$5.44 M-22.38%
December 31, 2024
Summary
- As of March 10, 2025, LAB quarterly earnings before interest & taxes is -$29.74 million, with the most recent change of -$5.44 million (-22.38%) on December 31, 2024.
- Over the past year, LAB quarterly EBIT has stayed the same.
- LAB quarterly EBIT is now -1111.74% below its all-time high of -$2.45 million, reached on December 1, 2009.
Performance
LAB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$134.76 M
-$8.23 M-6.51%
December 31, 2024
Summary
- As of March 10, 2025, LAB TTM earnings before interest & taxes is -$134.76 million, with the most recent change of -$8.23 million (-6.51%) on December 31, 2024.
- Over the past year, LAB TTM EBIT has stayed the same.
- LAB TTM EBIT is now -5391.32% below its all-time high of -$2.45 million, reached on December 1, 2009.
Performance
LAB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LAB EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -93.5% | 0.0% | 0.0% |
| 3 y3 years | -125.2% | 0.0% | 0.0% |
| 5 y5 years | -115.9% | 0.0% | 0.0% |
LAB EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -125.2% | +28.6% | -224.2% | +60.8% | -125.2% | +28.6% |
| 5 y | 5-year | -166.7% | +28.6% | -455.1% | +60.8% | -192.5% | +28.6% |
| alltime | all time | -819.1% | +28.6% | -1111.7% | +60.8% | -5391.3% | +28.6% |
Standard BioTools EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$134.76 M(+93.5%) | -$29.74 M(+22.4%) | -$134.76 M(+6.5%) |
| Sep 2024 | - | -$24.30 M(-42.1%) | -$126.53 M(+5.7%) |
| Jun 2024 | - | -$41.99 M(+8.4%) | -$119.73 M(+28.8%) |
| Mar 2024 | - | -$38.73 M(+80.1%) | -$92.93 M(+33.4%) |
| Dec 2023 | -$69.64 M(-63.1%) | -$21.50 M(+22.8%) | -$69.64 M(+2.8%) |
| Sep 2023 | - | -$17.51 M(+15.3%) | -$67.72 M(-14.6%) |
| Jun 2023 | - | -$15.18 M(-1.7%) | -$79.30 M(-38.1%) |
| Mar 2023 | - | -$15.44 M(-21.1%) | -$128.21 M(-32.0%) |
| Dec 2022 | -$188.60 M(+215.2%) | -$19.59 M(-32.7%) | -$188.60 M(+5.8%) |
| Sep 2022 | - | -$29.09 M(-54.6%) | -$178.18 M(+9.1%) |
| Jun 2022 | - | -$64.09 M(-15.5%) | -$163.39 M(+40.8%) |
| Mar 2022 | - | -$75.83 M(+726.9%) | -$116.06 M(+94.0%) |
| Dec 2021 | -$59.84 M(+18.4%) | -$9.17 M(-35.9%) | -$59.84 M(-10.4%) |
| Sep 2021 | - | -$14.30 M(-14.7%) | -$66.81 M(+15.4%) |
| Jun 2021 | - | -$16.76 M(-14.5%) | -$57.88 M(+6.4%) |
| Mar 2021 | - | -$19.61 M(+21.4%) | -$54.37 M(+7.6%) |
| Dec 2020 | -$50.53 M(-19.1%) | - | - |
| Dec 2020 | - | -$16.15 M(+201.5%) | -$50.53 M(+9.7%) |
| Sep 2020 | - | -$5.36 M(-59.6%) | -$46.07 M(-15.2%) |
| Jun 2020 | - | -$13.26 M(-15.8%) | -$54.32 M(-2.1%) |
| Mar 2020 | - | -$15.76 M(+34.8%) | -$55.46 M(-11.2%) |
| Dec 2019 | -$62.43 M(+31.3%) | - | - |
| Dec 2019 | - | -$11.69 M(-14.1%) | -$62.43 M(+1.2%) |
| Sep 2019 | - | -$13.61 M(-5.5%) | -$61.68 M(+3.5%) |
| Jun 2019 | - | -$14.40 M(-36.6%) | -$59.58 M(+3.3%) |
| Mar 2019 | - | -$22.72 M(+107.6%) | -$57.71 M(+21.4%) |
| Dec 2018 | -$47.53 M(-18.0%) | -$10.95 M(-4.9%) | -$47.53 M(+4.5%) |
| Sep 2018 | - | -$11.51 M(-8.1%) | -$45.50 M(-7.5%) |
| Jun 2018 | - | -$12.53 M(-0.1%) | -$49.21 M(-7.1%) |
| Mar 2018 | - | -$12.54 M(+40.6%) | -$52.99 M(-8.6%) |
| Dec 2017 | -$57.98 M | -$8.92 M(-41.4%) | -$57.98 M(-14.0%) |
| Sep 2017 | - | -$15.22 M(-6.6%) | -$67.39 M(-4.8%) |
| Jun 2017 | - | -$16.30 M(-7.0%) | -$70.81 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$17.53 M(-4.4%) | -$72.69 M(-2.2%) |
| Dec 2016 | -$74.36 M(+51.8%) | -$18.34 M(-1.7%) | -$74.36 M(+9.9%) |
| Sep 2016 | - | -$18.64 M(+2.5%) | -$67.65 M(+18.3%) |
| Jun 2016 | - | -$18.19 M(-5.2%) | -$57.19 M(+7.8%) |
| Mar 2016 | - | -$19.19 M(+65.0%) | -$53.05 M(+8.3%) |
| Dec 2015 | -$48.98 M(-6.5%) | -$11.63 M(+42.2%) | -$48.98 M(+2.6%) |
| Sep 2015 | - | -$8.18 M(-41.8%) | -$47.73 M(-9.3%) |
| Jun 2015 | - | -$14.05 M(-7.1%) | -$52.61 M(+3.3%) |
| Mar 2015 | - | -$15.12 M(+45.6%) | -$50.95 M(-2.7%) |
| Dec 2014 | -$52.36 M(+219.8%) | -$10.38 M(-20.5%) | -$52.36 M(+12.4%) |
| Sep 2014 | - | -$13.05 M(+5.3%) | -$46.58 M(+23.3%) |
| Jun 2014 | - | -$12.39 M(-25.0%) | -$37.77 M(+28.5%) |
| Mar 2014 | - | -$16.53 M(+259.4%) | -$29.40 M(+79.6%) |
| Dec 2013 | -$16.38 M(-10.3%) | -$4.60 M(+8.4%) | -$16.38 M(+6.8%) |
| Sep 2013 | - | -$4.24 M(+5.3%) | -$15.33 M(+1.7%) |
| Jun 2013 | - | -$4.03 M(+15.0%) | -$15.07 M(-2.3%) |
| Mar 2013 | - | -$3.50 M(-1.5%) | -$15.42 M(-15.6%) |
| Dec 2012 | -$18.26 M(-4.9%) | -$3.56 M(-10.8%) | -$18.26 M(+3.0%) |
| Sep 2012 | - | -$3.98 M(-9.0%) | -$17.74 M(-0.3%) |
| Jun 2012 | - | -$4.38 M(-31.0%) | -$17.78 M(-11.2%) |
| Mar 2012 | - | -$6.34 M(+109.3%) | -$20.02 M(+4.2%) |
| Dec 2011 | -$19.20 M(+31.0%) | -$3.03 M(-24.8%) | -$19.20 M(+2.3%) |
| Sep 2011 | - | -$4.03 M(-39.1%) | -$18.77 M(+6.7%) |
| Jun 2011 | - | -$6.61 M(+19.6%) | -$17.59 M(+16.5%) |
| Mar 2011 | - | -$5.53 M(+112.8%) | -$15.11 M(+3.0%) |
| Dec 2010 | -$14.66 M(-10.1%) | -$2.60 M(-8.9%) | -$14.66 M(+1.0%) |
| Sep 2010 | - | -$2.85 M(-30.8%) | -$14.52 M(+24.5%) |
| Jun 2010 | - | -$4.12 M(-18.9%) | -$11.66 M(+54.7%) |
| Mar 2010 | - | -$5.09 M(+107.3%) | -$7.54 M(+207.3%) |
| Dec 2009 | -$16.30 M(-41.0%) | -$2.45 M | -$2.45 M |
| Dec 2008 | -$27.61 M(+22.4%) | - | - |
| Dec 2007 | -$22.56 M(+5.9%) | - | - |
| Dec 2006 | -$21.29 M | - | - |
FAQ
- What is Standard BioTools annual earnings before interest & taxes?
- What is the all time high annual EBIT for Standard BioTools?
- What is Standard BioTools annual EBIT year-on-year change?
- What is Standard BioTools quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Standard BioTools?
- What is Standard BioTools quarterly EBIT year-on-year change?
- What is Standard BioTools TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Standard BioTools?
- What is Standard BioTools TTM EBIT year-on-year change?
What is Standard BioTools annual earnings before interest & taxes?
The current annual EBIT of LAB is -$134.76 M
What is the all time high annual EBIT for Standard BioTools?
Standard BioTools all-time high annual earnings before interest & taxes is -$14.66 M
What is Standard BioTools annual EBIT year-on-year change?
Over the past year, LAB annual earnings before interest & taxes has changed by -$65.12 M (-93.51%)
What is Standard BioTools quarterly earnings before interest & taxes?
The current quarterly EBIT of LAB is -$29.74 M
What is the all time high quarterly EBIT for Standard BioTools?
Standard BioTools all-time high quarterly earnings before interest & taxes is -$2.45 M
What is Standard BioTools quarterly EBIT year-on-year change?
Over the past year, LAB quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Standard BioTools TTM earnings before interest & taxes?
The current TTM EBIT of LAB is -$134.76 M
What is the all time high TTM EBIT for Standard BioTools?
Standard BioTools all-time high TTM earnings before interest & taxes is -$2.45 M
What is Standard BioTools TTM EBIT year-on-year change?
Over the past year, LAB TTM earnings before interest & taxes has changed by $0.00 (0.00%)